New “First” Program: Six Months of Free Lab Space for Eligible First-Time Biotech Founders >

Search

Rubius Therapeutics Closes $100 Million Financing

Generation Bio raises $100M for ‘druglike’ gene therapy

LabCentral Gallery 1832 Features 68-Piece Retrospective from Nobel Laureate in Chemistry and Internationally Acclaimed Digital Photographer Wally Gilbert

Nosocomial Vaccine Corporation Announces Presentation on Multivalent Vaccine for Gram-Negative Pathogens, including Multiple Antibiotic-Resistant Strains at World Vaccine Conference

Dr. Monika Weber - CEO of Fluid Screen - Disrupting traditional Petri Dish Methods for Bacterial Testing

Doctors say 'superblood' may work against deadly malignancies

Cedilla Therapeutics Launches with $56.2 Million

Inside a tiny Cambridge biotech’s plot to make cancer self-destruct

Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies

Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases